Shinobi Therapeutics

0 followers

‌

Shinobi Therapeutics is developing a new class of hypoimmune CD8ab iPS-T cells for cancer and beyond by using immune evasion to unlock the full potential of iPSCs.

Industries

Biotechnology, Life Sciences

Headquarters

South San Francisco, United States

Employees

11-50

Links

Org chart

Chief Executive Officer

Collapse

VP US Operations & HR

Chief Of Staff

Head Of BD And R&d Strategy

Teams

This company has no teams yet

Offices

HQ
4 people · 0 jobs

Tango Therapeutics

3 followers

Science

7 followers

Cellares

5 followers

Amgen

313 followers

Revvity

12 followers

Gilead Sciences

190 followers

Regeneron

158 followers

Illumina

85 followers

Agilent Technologies

94 followers

Verily Life Sciences

48 followers

Alexion Pharmaceuticals

52 followers

Shinobi Therapeutics

Org chart

Teams

Offices

Related companies